Published in Vaccine Weekly, October 11th, 1999
The study, the largest ever performed in melanoma, has enrolled over 850 patients at approximately 300 medical centers throughout the United States. The trial will close to further enrollment on October 15, 1999, and will have exceeded the targeted number of patients. The trial is being conducted by the National Cancer...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly